Top Markets
Coin of the day
Cambium Bio Limited Cambium Bio Limited

Cambium Bio Limited

CMB
Rangering i aksjer #33320
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Aksjekurs
$0.28211392
Markedsverdi
$8.30M
Endring (1 dag)
11.11%
Endring (1 år)
17.21%
Land
AU
Handel Cambium Bio Limited (CMB)

Kategori

Utbytteavkastning for Cambium Bio Limited (CMB)
Cambium Bio Limited (aksjesymbol: CMB) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Cambium Bio Limited (CMB) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter